Patents by Inventor David Gordon Trist

David Gordon Trist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of cck-b receptor antagonists for the treatment of sleep disorders
    Patent number: 6413930
    Abstract: The use of CCK-B antagonists for the treatment of sleep disorders.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: July 2, 2002
    Assignee: Glaxo Wellcome Spa
    Inventors: Emiliangelo Ratti, David Gordon Trist, Giovanni Gaviraghi, Francesco Crespi, Angelo Mario Reggiani
  • 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists
    Patent number: 5641775
    Abstract: The invention relates to 3-phenylureido-1,5-benzodiazepine-diones of formula (I) ##STR1## and pharmaceutically acceptable salts and solvates thereof, and to their use as gastrin/CCK-B antagonists.
    Type: Grant
    Filed: October 23, 1995
    Date of Patent: June 24, 1997
    Assignee: Glaxo SpA
    Inventors: Harry Finch, David Gordon Trist, Aldo Feriani, Giorgio Tarzia, Pritom Shah